Search Ontology:
ChEBI
alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-[alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->4)]-alpha-D-Manp-(1->3)-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc-yl group
- Term ID
- CHEBI:132214
- Synonyms
-
- 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->2)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyra
- alpha-Neu5Ac-(2-3)-beta-D-Gal-(1-4)-beta-D-GlcNAc-(1-2)-[alpha-Neu5Ac-(2-3)-beta-D-Gal-(1-4)-beta-D-GlcNAc-(1-4)]-alpha-D-Man-(1-3)-beta-D-Man-(1-4)-beta-D-GlcNAc-(1-4)-D-GlcNAc-yl
- alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-[alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->4)]-alpha-D-Man-(1->3)-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc-yl
- N-acetyl-alpha-neuraminyl-(2-3)-beta-D-galactosyl-(1-4)-N-acetyl-beta-D-glucosaminyl-(1-2)-[N-acetyl-alpha-neuraminyl-(2-3)-beta-D-galactosyl-(1-4)-N-acetyl-beta-D-glucosaminyl-(1-4)]-alpha-D-mannosyl-(1-3)-beta-D-mannosyl-(1-4)-N-acetyl-beta-D-glucosamin
- N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-[N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)]-alpha-D-mannosyl-(1->3)-beta-D-mannosyl-(1->4)-N-acetyl-beta-D-gl
- Neu5Acalpha2-3Galbeta1-4GlcNAcbeta1-2[Neu5Acalpha2-3Galbeta1-4GlcNAcbeta1-4]Manalpha1-3Manbeta1-4GlcNAcbeta1-4GlcNAc1-4-yl
- Definition
- A branched ten-residue glucosaminyl group consisting of a linear sequence of two D-mannosyl and two N-acetyl-D-glucosaminyl residues linked sequentially alpha(1->3), beta(1->4) and beta(1->4), to the mannosyl residue at the non-reducing end of which are linked beta(1->2) and beta(1->4) two N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl linear trisaccharide units.
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
Phenotype
Phenotype resulting from alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-[alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->4)]-alpha-D-Manp-(1->3)-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc-yl group
Phenotype where environments contain alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-[alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->4)]-alpha-D-Manp-(1->3)-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc-yl group
Phenotype modified by environments containing alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-[alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->4)]-alpha-D-Manp-(1->3)-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc-yl group
Human Disease Model